Production & Manufacturing
News
Catalent Invests $130 Million to Add Additional Manufacturing Capacity at its Gene Therapy Campus in Harmans, Maryland
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it is investing $130 million to add five additional Phase 3 through commercial-scale...
Drug Research
Memo Therapeutics and Northway Biotech collaborate on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19
Swiss biotech company Memo Therapeutics AG (MTx), and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx’s therapeutic COVID-19 antibody candidate in a 4 month fast-track process approved by...
Press Releases
Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-1
Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the...
Press Releases
Catalent Gene Therapy Facility Receives FDA Approval as an Additional Manufacturing Site for AveXis Gene Therapy
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it was approved by the U.S. FDA to produce commercial drug substance intermediate...
Press Releases
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19
Grand River Aseptic Manufacturing, a leading parenteral contract development and manufacturing organization (CDMO), has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United States’...
Press Releases
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it will expand its Argentinian site in Loma Hermosa, Buenos Aires. The expansion,...
Press Releases
Lonza’s Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301
We are committed to supporting Kodiak as they bring their highly innovative, sight-saving treatment option to patients with vision-threatening retinal diseases. Since 2014, we have been partnering with Kodiak to support the supply of KSI-301 drug substance for use...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.